REQUEST A DEMO
Total
USD $0.00
Search more companies

Mabwell (Shanghai) Bioscience Co., Ltd. (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Mabwell (Shanghai) Bioscience Co., Ltd. Profile Updated: May 12, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Mabwell (Shanghai) Bioscience Co., Ltd. is an innovative biopharmaceutical enterprise. The company's main business is the research and development, production and sales of therapeutic biological products, specifically antibody drugs including human therapeutic monoclonal antibodies, bispecific/bifunctional antibodies and ADC drugs, as well as long-acting or specially modified drugs and cytokine recombinant protein drugs. The company was established in 2017 and is headquartered in Shanghai, China.

Headquarters
Room 105, Building 2, No. 230, Cailun Road, Pudong New Area Pilot Free Trade Zone, Shanghai
Shanghai; Shanghai; Postal Code: 201210

Contact Details: Purchase the Mabwell (Shanghai) Bioscience Co., Ltd. report to view the information.

Website: http://mabwell.com

Basic Information
Total Employees:
Purchase the Mabwell (Shanghai) Bioscience Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Mabwell (Shanghai) Bioscience Co., Ltd. report to view the information.
Registered Capital:
Purchase the Mabwell (Shanghai) Bioscience Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Mabwell (Shanghai) Bioscience Co., Ltd. report to view the information.
Incorporation Date:
May 12, 2017
Key Executives
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
35.18%
Purchase this report to view the information.
5.01%
Purchase this report to view the information.
3.86%
Purchase this report to view the information.
3.78%
Purchase this report to view the information.
2.77%
Subsidiaries
Beijing Kenuo Xincheng Technology Co., Ltd.
100%
Desiteli Biotech
100%
Jiangsu Maiwei Pharmaceutical Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Mabwell (Shanghai) Bioscience Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
1572.43%
Total operating revenue
1711.67%
Operating profit (EBIT)
14.4%
EBITDA
13.8%
Net Profit (Loss) for the Period
14.68%
Total assets
-0.25%
Total equity
-27.41%
Operating Profit Margin (ROS)
5658.57%
Net Profit Margin
5678.51%
Return on Equity (ROE)
-1.29%
Debt to Equity Ratio
47.44%
Quick Ratio
-2.98%
Cash Ratio
-2.87%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?